Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002078421 | SCV002375122 | likely benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003007025 | SCV003591100 | uncertain significance | Inborn genetic diseases | 2022-03-29 | criteria provided, single submitter | clinical testing | The c.1841G>C (p.R614P) alteration is located in exon 13 (coding exon 13) of the ADAMTS17 gene. This alteration results from a G to C substitution at nucleotide position 1841, causing the arginine (R) at amino acid position 614 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |